Contribution of sedative-hypnotic agents to delirium via modulation of the sleep pathway

Canadian Journal of Anesthesia

Volumn 58, Issue 2, 2011, Pages 149-156

  Sanders, Robert D ^a   Maze, Mervyn ^b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BENZODIAZEPINE DERIVATIVE; DEXMEDETOMIDINE; HYPNOTIC SEDATIVE AGENT; LORAZEPAM; MIDAZOLAM;

ACUTE CONFUSION; COGNITIVE DEFECT; COMA; DECLARATIVE MEMORY; DELIRIUM; DISEASE PREDISPOSITION; DRUG RECEPTOR BINDING; EXPLICIT MEMORY; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; MEMORY DISORDER; NONHUMAN; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SEDATION; SLEEP;

ADRENERGIC ALPHA-AGONISTS; ANIMALS; COGNITION DISORDERS; DELIRIUM; HOSPITALIZATION; HUMANS; HYPNOTICS AND SEDATIVES; INTENSIVE CARE UNITS; LENGTH OF STAY; MEMORY; RECEPTORS, GABA-A; RISK FACTORS; SLEEP;

EID: 79951725860     PISSN: 0832610X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12630-010-9421-2     Document Type: Review

References (52)

1. Achermann P, Borbely AA. Mathematical models of sleep regulation. Front Biosci 2003; 8: s683-93.
2. Walker MP, Stickgold R. Sleep-dependent learning and memory consolidation. Neuron 2004; 44: 121-33. (Pubitemid 39348835)
3. Saper CB, Scammell TE, Lu J. Hypothalamic regulation of sleep and circadian rhythms. Nature 2005; 437: 1257-63. (Pubitemid 41568665)
4. Takahashi Y, Kipnis DM, Daughaday WH. Growth hormone secretion during sleep. J Clin Invest 1968; 47: 2079-90.
5. Tononi G, Cirelli C. Sleep function and synaptic homeostasis. Sleep Med Rev 2006; 10: 49-62. (Pubitemid 43106851)
6. Vyazovskiy VV, Cirelli C, Pfister-Genskow M, Faraguna U, Tononi G. Molecular and electrophysiological evidence for net synaptic potentiation in wake and depression in sleep. Nat Neurosci 2008; 11: 200-8. (Pubitemid 351170495)
7. Fenn KM, Nusbaum HC, Margoliash D. Consolidation during sleep of perceptual learning of spoken language. Nature 2003; 425: 614-6. (Pubitemid 37280143)
8. Braun AR, Balkin TJ, Wesenten NJ, et al. Regional cerebral blood flow throughout the sleep-wake cycle. An H2(15)O PET study. Brain 1997; 120(Pt 7): 1173-97.
9. Knott GW, Quairiaux C, Genoud C, Welker E. Formation of dendritic spines with GABAergic synapses induced by whisker stimulation in adult mice. Neuron 2002; 34: 265-73. (Pubitemid 34442569)
10. Yoo SS, Hu PT, Gujar N, Jolesz FA, Walker MP. A deficit in the ability to form new human memories without sleep. Nat Neurosci 2007; 10: 385-92.
11. Walker MP, Brakefield T, Hobson JA, Stickgold R. Dissociable stages of human memory consolidation and reconsolidation. Nature 2003; 425: 616-20. (Pubitemid 37280144)
12. Walker MP, Brakefield T, Seidman J, Morgan A, Hobson JA, Stickgold R. Sleep and the time course of motor skill learning. Learn Mem 2003; 10: 275-84. (Pubitemid 37013067)
13. Walker MP. Cognitive consequences of sleep and sleep loss. Sleep Med 2008; 9(Suppl 1): S29-34.
14. Aurell J, Elmqvist D. Sleep in the surgical intensive care unit: continuous polygraphic recording of sleep in nine patients receiving postoperative care. Br Med J (Clin Res Ed) 1985; 290: 1029-32. (Pubitemid 15109946)
15. Hilton BA. Quantity and quality of patients' sleep and sleep-disturbing factors in a respiratory intensive care unit. J Adv Nurs 1976; 1: 453-68.
16. Freedman NS, Gazendam J, Levan L, Pack AI, Schwab RJ. Abnormal sleep/wake cycles and the effect of environmental noise on sleep disruption in the intensive care unit. Am J Respir Crit Care Med 2001; 163: 451-7. (Pubitemid 32158527)
17. Pandharipande PP, Pun BT, Herr DL, et al. Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial. JAMA 2007; 298: 2644-53. (Pubitemid 350254956)
18. Riker RR, Shehabi Y, Bokesch PM, et al. Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial. JAMA 2009; 301: 489-99.
19. Pandharipande P, Shintani A, Peterson J, et al. Lorazepam is an independent risk factor for transitioning to delirium in intensive care unit patients. Anesthesiology 2006; 104: 21-6.
20. Pisani MA, Murphy TE, Araujo KL, Slattum P, Van Ness PH, Inouye SK. Benzodiazepine and opioid use and the duration of intensive care unit delirium in an older population. Crit Care Med 2009; 37: 177-83.
21. Cammarano WB, Pittet JF, Weitz S, Schlobohm RM, Marks JD. Acute withdrawal syndrome related to the administration of analgesic and sedative medications in adult intensive care unit patients. Crit Care Med 1998; 26: 676-84. (Pubitemid 28201413)
22. Rudolph U, Crestani F, Benke D, et al. Benzodiazepine actions mediated by specific gamma-aminobutyric acid(A) receptor subtypes. Nature 1999; 401: 796-800.
23. Tobler I, Kopp C, Deboer T, Rudolph U. Diazepam-induced changes in sleep: role of the alpha 1 GABA(A) receptor subtype. Proc Natl Acad Sci U S A 2001; 98: 6464-9. (Pubitemid 32488260)
24. Kopp C, Rudolph U, Low K, Tobler I. Modulation of rhythmic brain activity by diazepam: GABA(A) receptor subtype and state specificity. Proc Natl Acad Sci U S A 2004; 101: 3674-9. (Pubitemid 38338253)
25. Borbely AA, Achermann P. Ultradian dynamics of sleep after a single dose of benzodiazepine hypnotics. Eur J Pharmacol 1991; 195: 11-8.
26. Tan KR, Brown M, Labouebe G, et al. Neural bases for addictive properties of benzodiazepines. Nature 2010; 463: 769-74.
27. Nelson LE, Guo TZ, Lu J, Saper CB, Franks NP, Maze M. The sedative component of anesthesia is mediated by GABA(A) receptors in an endogenous sleep pathway. Nat Neurosci 2002; 5: 979-84.
28. Zecharia AY, Nelson LE, Gent TC, et al. The involvement of hypothalamic sleep pathways in general anesthesia: testing the hypothesis using the GABAA receptor beta3N265 M knock-in mouse. J Neurosci 2009; 29: 2177-87.
29. Tung A, Bergmann BM, Herrera S, Cao D, Mendelson WB. Recovery from sleep deprivation occurs during propofol anesthesia. Anesthesiology 2004; 100: 1419-26. (Pubitemid 38679311)
30. Savic MM, Obradovic DI, Ugresic ND, Bokonjic DR. Memory effects of benzodiazepines: memory stages and types versus binding-site subtypes. Neural Plast 2005; 12: 289-98. (Pubitemid 43072005)
31. Park H, Quinlan J, Thornton E, Reder LM. The effect of midazolam on visual search: implications for understanding amnesia. Proc Natl Acad Sci U S A 2004; 101: 17879-83. (Pubitemid 40051980)
32. Stewart SH, Buffett-Jerrott SE, Finley GA, Wright KD, Valois Gomez T. Effects of midazolam on explicit vs implicit memory in a pediatric surgery setting. Psychopharmacology (Berl) 2006; 188: 489-97. (Pubitemid 46758960)
33. Lakhlani PP, MacMillan LB, Guo TZ, et al. Substitution of a mutant alpha2a-adrenergic receptor via "hit and run" gene targeting reveals the role of this subtype in sedative, analgesic, and anesthetic-sparing responses in vivo. Proc Natl Acad Sci U S A 1997; 94: 9950-5.
34. Correa-Sales C, Nacif-Coelho C, Reid K, Maze M. Inhibition of adenylate cyclase in the locus coeruleus mediates the hypnotic response to an alpha 2 agonist in the rat. J Pharmacol Exp Ther 1992; 263: 1046-9. (Pubitemid 23157178)
35. Correa-Sales C, Rabin BC, Maze M. A hypnotic response to dexmedetomidine, an alpha 2 agonist, is mediated in the locus coeruleus in rats. Anesthesiology 1992; 76: 948-52.
36. Correa-Sales C, Reid K, Maze M. Pertussis toxin-mediated ribosylation of G proteins blocks the hypnotic response to an alpha 2-agonist in the locus coeruleus of the rat. Pharmacol Biochem Behav 1992; 43: 723-7.
37. Nacif-Coelho C, Correa-Sales C, Chang LL, Maze M. Perturbation of ion channel conductance alters the hypnotic response to the alpha 2-adrenergic agonist dexmedetomidine in the locus coeruleus of the rat. Anesthesiology 1994; 81: 1527-34. (Pubitemid 24381446)
38. Nelson LE, Lu J, Guo T, Saper CB, Franks NP, Maze M. The alpha2-adrenoceptor agonist dexmedetomidine converges on an endogenous sleep-promoting pathway to exert its sedative effects. Anesthesiology 2003; 98: 428-36. (Pubitemid 36592812)
39. Lu J, Greco MA. Sleep circuitry and the hypnotic mechanism of GABAA drugs. J Clin Sleep Med 2006; 2: S19-26.
40. Coull JT, Jones ME, Egan TD, Frith CD, Maze M. Attentional effects of noradrenaline vary with arousal level: selective activation of thalamic pulvinar in humans. Neuroimage 2004; 22: 315-22. (Pubitemid 38515837)
41. Huupponen E, Maksimow A, Lapinlampi P, et al. Electroencephalogram spindle activity during dexmedetomidine sedation and physiological sleep. Acta Anaesthesiol Scand 2008; 52: 289-94.
42. Mason KP, O'Mahony E, Zurakowski D, Libenson MH. Effects of dexmedetomidine sedation on the EEG in children. Paediatr Anaesth 2009; 19: 1175-83.
43. Hsu YW, Cortinez LI, Robertson KM, et al. Dexmedetomidine pharmacodynamics: part I: crossover comparison of the respiratory effects of dexmedetomidine and remifentanil in healthy volunteers. Anesthesiology 2004; 101: 1066-76. (Pubitemid 39430785)
44. Kallio A, Scheinin M, Koulu M, et al. Effects of dexmedetomidine, a selective alpha 2-adrenoceptor agonist, on hemodynamic control mechanisms. Clin Pharmacol Ther 1989; 46: 33-42. (Pubitemid 19195772)
45. Thornton C, Lucas MA, Newton DE, Dore CJ, Jones RM. Effects of dexmedetomidine on isoflurane requirements in healthy volunteers. 2: Auditory and somatosensory evoked responses. Br J Anaesth 1999; 83: 381-6.
46. Veselis RA, Pryor KO, Reinsel RA, Li Y, Mehta M, Johnson R Jr. Propofol and midazolam inhibit conscious memory processes very soon after encoding: an event-related potential study of familiarity and recollection in volunteers. Anesthesiology 2009; 110: 295-312.
47. Sirvio J, Riekkinen P Jr, Ekonsalo T, Lammintausta R, Riekkinen PJ. The effects of dexmedetomidine, an alpha 2 agonist, on learning and memory, assessed using passive avoidance and water maze tasks in rats. Neuropharmacology 1992; 31: 163-8.
48. van Oostrom H, Stienen PJ, Doornenbal A, Hellebrekers LJ. The alpha(2)-adrenoceptor agonist dexmedetomidine suppresses memory formation only at doses attenuating the perception of sensory input. Eur J Pharmacol 2010; 629: 58-62.
49. Pandharipande PP, Sanders RD, Girard TD, et al. Effect of dexmedetomidine versus lorazepam on outcome in patients with sepsis: an a priori-designed analysis of the MENDS randomized controlled trial. Crit Care 2010; 14: R38.
50. Sanders RD, Hussell T, Maze M. Sedation & immunomodulation. Crit Care Clin 2009; 25: 551-70, ix.
51. Kress JP, Pohlman AS, O'Connor MF, Hall JB. Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation. N Engl J Med 2000; 342: 1471-7. (Pubitemid 30318270)
52. Girard TD, Kress JP, Fuchs BD, Thomason JW, et al. Efficacy and safety of a paired sedation and ventilator weaning protocol for mechanically ventilated patients in intensive care (Awakening and Breathing Controlled trial): a randomised controlled trial. Lancet 2008; 371: 126-34.